9164 An indirect comparison of the efficacy of bevacizumab plus cisplatin and gemcitabine (BCG) or bevacizumab plus carboplatin and paclitaxel (BCP) versus pemetrexed plus cisplatin (PC) and cetuximab plus vinorelbine and cisplatin (CVC) in patients (pts) with advanced or recurrent non-small cell cancer (NSCLC)
Walzer, S., de Castro Carpeno, J., Vergnenegre, A.V., Chouaid, C., Heigener, D.F.H., Bischoff, H.G., Nicolson, M.C., Aultman, R., Siebert, U.Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71877-4
Date:
September, 2009
File:
PDF, 48 KB
english, 2009
File converter
More search results
More benefits 
